Katahdin Bankshares press release (KTHN): Q2 GAAP EPS of $0.76. - The second quarter provided continued loan growth of $47.4 million or 5.4%. This strong quarter put total loans at $930.5 million, an increase of 9.9% over the past year Total assets reached $1.16 bil
Brown & Brown reports $1.07 non-GAAP EPS Brown & Brown reported non-GAAP earnings per share of $1.07, in line with expectations. The company's revenue of $1.68 billion was a 31.3% increase year over year, but missed estimates by $40 million. For the six months
Happen raises full-year GAAP EPS guidance to $1.80-$1.90, exceeding $1.75 consensus after strong Q2 loan originations. Happen (HAPN) reported Q2 earnings that surpassed analyst expectations, driven by higher-than-anticipated loan originations. The company’s after-hours sto
Universal Health Services lowers full-year earnings guidance to $22.28-$23.65 after second-quarter results fall short of estimates. Universal Health Services (UHS) reduced its 2026 non-GAAP EPS guidance to $22.28-$23.65 from the prior range of $22.64-$24.52. The revision f
BOH reports Q2 2026 diluted EPS of $1.47 and net income of $63.8 million while targeting year-end margin goals. Bank of Hawaii announced plans to repurchase $20 million in shares during Q3 2026, aiming to bolster shareholder returns. The move follows a quarter where the ba
Celestica shares jumped over 7% after strong Q2 results Celestica reported better-than-expected second quarter results. The company earned an adjusted $2.54 per share for the period ending June 30. This earnings report led to an increase in the company's sh
Principal Financial Group reports $2.42 non-GAAP EPS, topping estimates by $0.09, but stock declines in after-hours trading. Principal Financial Group (PFG) reported second-quarter non-GAAP earnings per share of $2.42, surpassing analyst estimates by $0.09. The company als
OPKO Health raised its 2026 revenue forecast to $560M-$585M after surpassing Q2 estimates on both revenue and earnings. OPKO Health (OPK) increased its full-year 2026 revenue guidance to $560M-$585M, up from the prior $520M-$560M range. The revised outlook follows stronger
Celestica reports Q2 revenue of $4.7 billion and lifts 2026 revenue forecast to $20.5 billion, exceeding expectations. Celestica posted Q2 non-GAAP earnings per share of $2.54, beating estimates by $0.23, as revenue surged 62.6% year-over-year to $4.7 billion, $310 million
Healthcare stocks WELL, UHS, and ESI surge in extended trading following a mixed session for major U.S. indexes. U.S. equities closed mixed on Monday as investors weighed geopolitical tensions in the Middle East. The S&P 500 remained unchanged, while the Nasdaq Composite d
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.